Mazzoni A, Danesi G, Zanoletti E
Formerly ENT Dept., Ospedali Riuniti, Bergamo; ; ENT-Otochirurgia, Ospedale-Università di Padova;
ENT Dept., Ospedali Riuniti, Bergamo.
Acta Otorhinolaryngol Ital. 2014 Apr;34(2):129-37.
This study was conducted on patients with squamous cell carcinoma of the external auditory canal and temporal bone treated with surgery alone or surgery plus postoperative radiotherapy. It was designed as a retrospective investigation with complete long-term follow-up covering the years from 1983 to 2008. The setting was a tertiary referral centre. Forty-one consecutive cases underwent surgery involving en bloc lateral or subtotal temporal bone resection, parotidectomy and neck dissection plus radiotherapy in advanced cases. The Pittsburgh staging system was adopted. No cases were lost to follow-up, which ranged from 2 to 220 months, while for survivors ranged from 60 to 220 months and included clinical examinations and imaging. Outcome was expressed as NED (no evidence of disease), DOC (dead of other causes), DOD (dead of disease), AWD (alive with disease), disease-free survival (DFS) and disease-specific survival (DSS). Results were expressed with raw data and Kaplan Meyer curves. Patients with T1 and T2 disease had a DFS of 67% and a DSS of 92%. For T3 and T4 cases, the DFS was 41% and DSS was 48%. All treatment failures were due to local recurrences. The cases classified as T4 because the lesion extended from the cartilage canal to the periauricular soft tissues, or from the anterior wall to the parotid space, had a better outcome than the other T4 cases: this different prognosis suggests the need to stage tumours differently. Nodal disease coincided with a worse outcome due to local recurrence.
本研究针对仅接受手术治疗或手术联合术后放疗的外耳道及颞骨鳞状细胞癌患者开展。该研究设计为一项回顾性调查,涵盖1983年至2008年的完整长期随访。研究地点为一家三级转诊中心。连续41例患者接受了手术,包括整块外侧或颞骨次全切除、腮腺切除术及颈部清扫术,晚期病例还接受了放疗。采用匹兹堡分期系统。无一例失访,随访时间为2至220个月,存活者的随访时间为60至220个月,随访内容包括临床检查和影像学检查。结果以无疾病证据(NED)、死于其他原因(DOC)、死于疾病(DOD)、带瘤生存(AWD)、无病生存期(DFS)和疾病特异性生存期(DSS)表示。结果以原始数据和Kaplan - Meyer曲线呈现。T1和T2期疾病患者的DFS为67%,DSS为92%。对于T3和T4期病例,DFS为41%,DSS为48%。所有治疗失败均归因于局部复发。因病变从软骨管延伸至耳周软组织或从前壁延伸至腮腺间隙而被归类为T4期的病例,其预后优于其他T4期病例:这种不同的预后表明需要对肿瘤进行不同的分期。淋巴结疾病因局部复发导致预后较差。